NPC-02

DRUG3 trials

Sponsors

Nobelpharma

Conditions

Wilson's DiseaseZinc Deficiency

Phase 3

Efficacy and Safety, Long-term Study of Zinc Acetate to Treat Wilson's Disease in Japan.

CompletedNCT00212355

NobelpharmaWilson's Disease

Start: 2005-03-31End: 2009-01-31Updated: 2025-03-05

Dose Adjustment Study of NPC-02 in Patients With Zinc Deficiency

CompletedNCT02321865

NobelpharmaZinc Deficiency

Start: 2015-01-21End: 2015-11-24Updated: 2019-04-16

A Randomized, Double-Blind, Placebo Controlled Study of NPC-02 in Patients With Zinc Deficiency

CompletedNCT02337569

NobelpharmaZinc Deficiency

Start: 2015-01-31End: 2015-11-30Updated: 2019-04-17

Related Papers

Effects of Zinc Acetate on Serum Zinc Concentrations in Chronic Liver Diseases: a Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial and a Dose Adjustment Trial

Biological Trace Element Research2019-08-0722 citations